https://www.pharmaceutical-technology.com/data-insights/gedatolisib-celcuity-net-present-value/ 2024-06-13T18:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/volrustomig-astrazeneca-net-present-value/ 2024-07-02T02:08:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrg-003-lepu-biopharma-net-present-value/ 2024-12-13T02:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ozuriftamab-vedotin-bioatla-net-present-value/ 2024-05-16T02:05:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/linvoseltamab-regeneron-pharmaceuticals-net-present-value/ 2024-07-02T02:07:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tagraxofusp-stemline-therapeutics-hypereosinophilic-syndrome-likelihood-of-approval/ 2025-01-19T17:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/clesrovimab-merck-net-present-value/ 2024-12-13T02:52:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trotabresib-bristol-myers-squibb-net-present-value/ 2024-06-13T18:52:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/feladilimab-gsk-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-19T16:53:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crinecerfont-neurocrine-biosciences-net-present-value/ 2024-12-13T02:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vorolanib-eyepoint-pharmaceuticals-net-present-value/ 2024-06-13T18:46:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ziltivekimab-novo-nordisk-net-present-value/ 2024-12-13T02:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zamaglutenase-takeda-pharmaceutical-net-present-value/ 2024-12-13T02:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camizestrant-astrazeneca-net-present-value/ 2024-12-13T02:52:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/favezelimab-merck-net-present-value/ 2024-07-02T02:08:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nbi-1065846-neurocrine-biosciences-net-present-value/ 2024-03-13T16:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/suvecaltamide-hydrochloride-jazz-pharmaceuticals-net-present-value/ 2024-06-13T18:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/terbinafine-hydrochloride-moberg-pharma-onychomycosis-tinea-unguium-likelihood-of-approval/ 2023-02-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sepiapterin-ptc-therapeutics-net-present-value/ 2024-06-13T18:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cutx-101-fortress-biotech-net-present-value/ 2024-06-13T18:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptide-to-antagonize-grpr-for-oncology-novartis-net-present-value/ 2024-07-02T02:08:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anx-007-annexon-net-present-value/ 2024-12-13T02:52:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dsg3-caart-cabaletta-bio-net-present-value/ 2024-12-13T02:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/giroctocogene-fitelparvovec-pfizer-net-present-value/ 2024-04-16T17:00:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/depemokimab-gsk-net-present-value/ 2024-12-13T02:52:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apatinib-mesylate-elevar-therapeutics-leiomyosarcoma-likelihood-of-approval/ 2025-01-19T16:40:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atacicept-vera-therapeutics-iga-nephropathy-berger-s-disease-likelihood-of-approval/ 2025-01-19T16:39:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trametinib-dimethyl-sulfoxide-novartis-relapsed-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:40:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vidofludimus-calcium-immunic-net-present-value/ 2024-05-16T02:04:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/obecabtagene-autoleucel-autolus-therapeutics-net-present-value/ 2024-06-13T18:48:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-duocarmazine-byondis-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-19T17:16:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/itepekimab-sanofi-net-present-value/ 2024-07-02T02:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cefepime-taniborbactam-hydrochloride-everest-medicines-net-present-value/ 2024-07-02T02:08:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mozafancogene-autotemcel-rocket-pharmaceuticals-net-present-value/ 2024-06-13T18:48:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rpl-301-rocket-pharmaceuticals-net-present-value/ 2024-06-13T18:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mrna-1647-moderna-net-present-value/ 2024-05-16T02:04:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vibostolimab-merck-net-present-value/ 2024-07-02T02:08:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fazirsiran-sodium-takeda-pharmaceutical-net-present-value/ 2024-12-13T02:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fazirsiran-sodium-arrowhead-pharmaceuticals-net-present-value/ 2024-12-13T02:50:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ifinatamab-deruxtecan-daiichi-sankyo-net-present-value/ 2024-12-13T02:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-astrazeneca-net-present-value/ 2024-07-02T02:08:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/datopotamab-deruxtecan-daiichi-sankyo-net-present-value/ 2024-07-02T02:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ixoberogene-soroparvovec-adverum-biotechnologies-net-present-value/ 2024-05-16T02:04:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tld-1433-theralase-technologies-net-present-value/ 2024-07-02T02:03:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/donidalorsen-sodium-ionis-pharmaceuticals-net-present-value/ 2024-07-02T02:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acoramidis-hydrochloride-bridgebio-pharma-net-present-value/ 2024-07-02T02:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/farletuzumab-ecteribulin-bristol-myers-squibb-net-present-value/ 2024-12-13T02:51:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/quavonlimab-merck-net-present-value/ 2024-07-02T02:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mezigdomide-bristol-myers-squibb-net-present-value/ 2024-06-13T18:52:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radspherin-oncoinvent-peritoneal-cancer-likelihood-of-approval/ 2025-01-19T16:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pipeline-uc-market/ 2023-02-23T16:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-calquence-cll/ 2023-02-23T14:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-life-edit-gene-therapies/ 2023-02-23T11:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bowel-cancer-screening/ 2023-02-23T10:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biohacking-response-flawed/ 2023-02-23T10:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-important-role-that-biopharmaceutics-plays-in-accelerating-early-phase-drug-development/ 2023-02-23T11:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genscript-probio-rvac-partner/ 2023-02-23T09:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olezarsen-sodium-ionis-pharmaceuticals-net-present-value/ 2024-12-13T02:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/letermovir-merck-human-immunodeficiency-virus-hiv-infections-aids-likelihood-of-approval/ 2025-01-19T16:44:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crizanlizumab-novartis-myelofibrosis-likelihood-of-approval/ 2023-05-31T18:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sasanlimab-pfizer-net-present-value/ 2024-06-13T18:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stalaris-atyr-pharma-net-present-value/ 2024-05-16T02:03:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lna-043-novartis-net-present-value/ 2024-04-16T16:59:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adct-602-adc-therapeutics-net-present-value/ 2024-05-16T02:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medi-7352-astrazeneca-net-present-value/ 2024-07-02T02:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/linerixibat-gsk-net-present-value/ 2024-04-16T16:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ima-203-immatics-net-present-value/ 2024-07-02T02:02:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iopofosine-i-131-cellectar-biosciences-net-present-value/ 2024-07-02T02:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/etripamil-milestone-pharmaceuticals-net-present-value/ 2024-06-13T18:46:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/batoclimab-immunovant-net-present-value/ 2024-06-13T18:47:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gepotidacin-mesylate-gsk-net-present-value/ 2024-12-13T02:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/men-1703-stemline-therapeutics-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2024-05-20T01:34:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mgd-014-macrogenics-human-immunodeficiency-virus-hiv-infections-aids-likelihood-of-approval/ 2024-04-19T00:28:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/minocycline-hydrochloride-er-promius-pharma-rosacea-likelihood-of-approval/ 2025-01-19T16:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dmt-310-dermata-therapeutics-acne-vulgaris-likelihood-of-approval/ 2024-09-09T01:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fitusiran-sanofi-net-present-value/ 2024-12-13T02:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitazalimab-alligator-bioscience-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-07-05T18:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esmethadone-hydrochloride-relmada-therapeutics-net-present-value/ 2024-06-13T18:46:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/venglustat-malate-sanofi-net-present-value/ 2024-04-16T16:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elx-02-eloxx-pharmaceuticals-alport-syndrome-likelihood-of-approval/ 2025-01-19T16:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulotaront-sumitomo-pharma-net-present-value/ 2024-12-13T02:50:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocatinlimab-kyowa-kirin-net-present-value/ 2024-12-13T02:50:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocatinlimab-amgen-net-present-value/ 2024-06-13T18:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-8326-advenchen-laboratories-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T01:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/danicamtiv-bristol-myers-squibb-net-present-value/ 2024-05-16T01:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fosifloxuridine-nafalbenamide-nucana-net-present-value/ 2024-05-16T02:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemvidutide-altimmune-net-present-value/ 2024-05-16T02:02:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/men-abcwy-gsk-net-present-value/ 2024-12-13T02:52:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olaptesed-pegol-tme-pharma-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2024-03-19T00:28:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fresolimumab-sanofi-non-small-cell-lung-cancer-likelihood-of-approval/ 2023-05-31T18:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onvansertib-fumarate-cardiff-oncology-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-19T16:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lacutamab-innate-pharma-net-present-value/ 2024-12-13T02:52:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anx-005-annexon-net-present-value/ 2024-12-13T02:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/briavax-briacell-therapeutics-net-present-value/ 2024-05-16T02:02:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pneumococcal-vaccine-cansino-biologics-net-present-value/ 2024-07-02T02:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/paltusotine-hydrochloride-crinetics-pharmaceuticals-carcinoid-syndrome-malignant-carcinoid-syndrome-likelihood-of-approval/ 2023-02-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imnn-001-imunon-epithelial-ovarian-cancer-likelihood-of-approval/ 2023-06-01T04:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iscalimab-novartis-net-present-value/ 2024-04-16T16:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cobolimab-gsk-net-present-value/ 2024-04-16T16:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/telisotuzumab-vedotin-abbvie-net-present-value/ 2024-04-16T16:58:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belantamab-mafodotin-gsk-refractory-multiple-myeloma-likelihood-of-approval/ 2025-01-19T16:44:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rilzabrutinib-sanofi-net-present-value/ 2024-07-02T02:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-06425090-pfizer-clostridioides-difficile-infections-clostridium-difficile-associated-disease-likelihood-of-approval/ 2023-02-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hb-101-hookipa-pharma-cytomegalovirus-hhv-5-infections-likelihood-of-approval/ 2023-02-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nemtabrutinib-merck-net-present-value/ 2024-07-02T02:07:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/com-701-compugen-net-present-value/ 2024-12-13T02:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blinatumomab-amgen-lymphoblastic-lymphoma-likelihood-of-approval/ 2025-01-19T16:57:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/soticlestat-takeda-pharmaceutical-net-present-value/ 2024-12-13T02:50:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aav-aqp1-meiragtx-net-present-value/ 2024-05-16T02:03:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psilocybin-what-is-the-likelihood-that-drug-will-be-approved/ 2023-08-10T17:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabatolimab-novartis-net-present-value/ 2024-06-13T18:51:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axitinib-clearside-biomedical-net-present-value/ 2024-05-16T02:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/treprostinil-palmitil-insmed-net-present-value/ 2024-06-13T18:47:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tolebrutinib-sanofi-net-present-value/ 2024-07-02T02:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c1-esterase-inhibitor-human-takeda-pharmaceutical-acquired-autoimmune-hemolytic-anemia-likelihood-of-approval/ 2025-01-19T17:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986012-bristol-myers-squibb-net-present-value/ 2024-07-02T02:07:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afx-3772-gsk-net-present-value/ 2024-12-13T02:52:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mass-extinction-of-start-ups-on-the-horizon-2023/ 2023-02-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/irl-201104-revolo-biotherapeutics-eosinophilic-esophagitis-likelihood-of-approval/ 2025-01-19T17:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atrn-119-aprea-therapeutics-net-present-value/ 2024-05-16T02:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/istaroxime-windtree-therapeutics-acute-heart-failure-likelihood-of-approval/ 2024-02-08T19:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cagrilintide-novo-nordisk-net-present-value/ 2024-12-13T02:51:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/brensocatib-insmed-net-present-value/ 2024-12-13T02:52:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/carfostin-asklepios-biopharmaceutical-congestive-heart-failure-heart-failure-likelihood-of-approval/ 2025-01-19T16:42:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pr-001-eli-lilly-and-co-net-present-value/ 2024-07-02T02:07:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arct-810-arcturus-therapeutics-net-present-value/ 2024-12-13T02:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cbp-501-canbas-pancreatic-cancer-likelihood-of-approval/ 2025-01-19T16:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pelacarsen-sodium-novartis-net-present-value/ 2024-07-02T02:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mevidalen-hydroxybenzoate-eli-lilly-and-co-net-present-value/ 2024-05-16T01:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lb-100-lixte-biotechnology-recurrent-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2025-01-19T16:40:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/patent-wars-whats-behind-amgens-possible-win-over-sanofi-at-the-us-supreme-court/ 2023-02-24T23:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ferrer-asceneuron-asn90-psp/ 2023-02-22T14:58:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-biohaven-taldefgrobep-alfa/ 2023-02-22T11:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/karyopharm-menarini-nexpovio-uk/ 2023-02-22T10:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-regeneron-pozelimab-bla/ 2023-02-21T15:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teijin-axcelead-drug-discovery-jv/ 2023-02-21T11:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-covid-vaccine-2022/ 2023-02-21T10:44:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/six-things-to-look-for-tablet-press-rd/ 2023-02-22T09:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-ec-haemophilia-b-gene-therapy/ 2023-02-21T08:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/which-countries-have-the-highest-level-of-inflation-in-2023/ 2023-02-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cerba-research-to-transform-research-and-advance-healthcare/ 2023-02-20T18:45:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cerba-research-and-teddy-lab-sign-memorandum-of-understanding-on-entering-into-a-discussion-for-joint-venture/ 2023-02-21T12:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-relapsing-multiple-sclerosis-rms-likelihood-of-approval/ 2025-01-19T16:34:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belantamab-mafodotin-gsk-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-19T16:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ruzasvir-atea-pharmaceuticals-hepatitis-c-likelihood-of-approval/ 2023-07-01T01:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabatolimab-novartis-post-essential-thrombocythemia-myelofibrosis-post-et-mf-likelihood-of-approval/ 2024-02-21T18:01:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/buntanetap-tartrate-annovis-bio-alzheimer-s-disease-likelihood-of-approval/ 2025-01-19T16:39:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lenvatinib-mesylate-eisai-osteosarcoma-likelihood-of-approval/ 2025-01-19T16:39:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-austedo-xr-tardive-dyskinesia/ 2023-02-20T15:48:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/frontotemporal-dementia-the-state-of-treatment-development/ 2023-02-24T23:48:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esreboxetine-axsome-therapeutics-net-present-value/ 2024-06-13T18:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sozinibercept-opthea-net-present-value/ 2024-05-16T02:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/belzupacap-sarotalocan-aura-biosciences-net-present-value/ 2024-05-16T02:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onvansertib-fumarate-cardiff-oncology-net-present-value/ 2024-06-13T18:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/felzartamab-i-mab-net-present-value/ 2024-12-13T02:51:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mirdametinib-springworks-therapeutics-net-present-value/ 2024-06-13T18:47:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eftilagimod-alfa-immutep-net-present-value/ 2024-12-13T02:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/setanaxib-calliditas-therapeutics-net-present-value/ 2024-07-02T02:06:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ampligen-aim-immunotech-net-present-value/ 2024-06-13T18:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ralinepag-united-therapeutics-net-present-value/ 2024-07-02T02:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clover-adimmune-influenza-vaccine/ 2023-02-20T11:43:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-apelliss-geographic-atrophy/ 2023-02-20T09:23:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-cities-need-an-arts-culture-boost-economic-level-up/ 2023-02-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/m2gen-zephyr-ai-cancer/ 2023-02-17T15:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capricor-nippon-shinyaku-dmd-therapy/ 2023-02-17T11:40:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fda-drug-dosage-optimisation-guidelines-signal-clinical-trial-reform/ 2023-02-17T10:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aqilion-merck-tak1-protein/ 2023-02-17T10:04:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/forever-young-ageing/ 2023-02-17T10:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/md-anderson-xilis-cancer-therapies/ 2023-04-21T14:40:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/wegovy-pharmacies-uk/ 2023-02-16T15:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bla-henlius-hlx02/ 2023-02-16T12:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eyenovia-formosa-ophthalmic-therapeutics/ 2023-02-16T08:59:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-igg-gene-expressing-animal-models-pharmaceutical/ 2023-02-16T06:18:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-gene-therapy-delivery-using-viral-vectors-pharmaceutical/ 2023-02-16T06:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-gene-splicing-using-nucleases-pharmaceutical/ 2024-08-29T04:26:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-embryonic-stem-cell-culturing-pharmaceutical-2/ 2024-07-30T09:34:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-dna-polymerase-compositions-pharmaceutical/ 2023-02-16T05:55:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-crispr-nucleases-pharmaceutical/ 2024-08-29T03:40:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-coronavirus-vaccine-components-pharmaceutical/ 2023-02-16T05:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-immuno-oncology-cancer-monoclonal-antibody-therapy-pharmaceutical/ 2023-02-16T06:22:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/chinas-fdi-decline-foreign-companies-covid-geopolitics/ 2023-02-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kinnate-kin-3248-fda-fast-track/ 2023-02-15T15:29:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/using-big-data-to-stabilise-pharma-supply-chains-in-an-age-of-disruption/ 2023-07-28T09:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/analytics-bioassays-mrna-lnp-drug-development/ 2023-03-01T11:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/similis-bio-novel351k-biosimilars/ 2023-02-15T11:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clover-covid-19-subunit-vaccine/ 2023-02-15T09:10:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corbus-cspc-megalith-antibody-drug-conjugate/ 2023-02-14T15:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-biosimilars-neuro-degenerative-receptor-binding-drug-compositions-pharmaceutical/ 2023-02-14T13:57:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-iot-nanoparticles-for-drug-delivery-pharmaceutical/ 2024-08-29T04:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-mammalian-expression-vectors-pharmaceutical/ 2023-02-14T13:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-kidney-disorder-treatment-compositions-pharmaceutical/ 2024-08-29T04:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-isotropically-modified-heterocyclic-compounds-pharmaceutical/ 2023-02-14T13:43:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-hepatitis-b-virus-hbv-peptides-pharmaceutical/ 2023-02-14T13:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cullinan-oncology-harbour-biomed/ 2023-02-14T12:11:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-covid-19-vaccine-doses/ 2023-02-14T12:11:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/london-vauxhall-nightlife-lgbtq-regeneration/ 2023-02-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-epilepsy-researchers-are-moving-the-needle-past-anti-seizure-treatments/ 2023-05-31T04:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/strategies-for-streamlining-small-molecule-formulation-development-when-bridging-from-candidate-selection-to-first-in-human-clinical-testing/ 2023-03-03T14:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sophia-genetics-astrazeneca-oncology-drugs/ 2023-02-23T14:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/protac-development/ 2023-02-13T12:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-cibinqo-atopic-dermatitis/ 2023-02-13T11:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scilex-acute-migraine-elyxyb/ 2023-02-13T08:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/4d-molecular-fabry/ 2023-05-22T07:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/dentistry-qa-cleaning-up-the-dental-antibiotic-resistance-problem/ 2023-04-26T15:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-full-year-2022-net-revenues/ 2023-02-10T14:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-nimbus-therapeutics-subsidiary/ 2023-02-10T10:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/risk-sharing-agreements/ 2023-02-10T15:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-of-sydney-protein-covid-19/ 2023-02-10T09:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-is-the-best-country-to-set-up-an-it-business/ 2023-02-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/higher-throughput-integrity-testing-defining-a-modern-ccit-system-for-the-demands-of-serial-production/ 2023-02-10T17:02:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-5-fall-q4-revenue/ 2023-02-09T14:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revir-asieris-oncology-therapies/ 2023-04-21T14:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-regeneron-eylea-retinopathy-prematurity/ 2023-02-09T08:20:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hull-film-production-location-yorkshire-tv-crown/ 2023-02-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gives-ways-to-curb-constraints-with-rare-disease-gene-therapy-trials/ 2023-02-10T22:01:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genenta-science-agc-biologics/ 2023-04-21T13:20:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-aldeyra-dry-eye-disease/ 2023-02-08T10:43:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-industry-growth/ 2023-02-09T17:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-heart-failure-therapy/ 2023-02-08T08:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-were-the-top-fdi-themes-in-2022/ 2023-02-07T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/early-planning-market-access-drug-launch/ 2024-01-29T16:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tga-vifors-tavneos-vasculitis/ 2023-02-07T14:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-takeda-dengue-vaccine/ 2023-02-07T11:40:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sandoz-biosimilar-denosumab/ 2023-02-07T08:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lebanons-private-sector-thriving-crisis-multilane/ 2023-02-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pliant-snags-287-5-million-in-oversubscribed-public-offering-amid-market-uncertainty/ 2023-02-06T18:17:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/feinstein-institutes-sepsis-treatment/ 2023-02-06T15:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/qurient-tb-alliance-telacebec/ 2023-07-03T04:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gilead-sciences-breast-cancer/ 2023-03-08T09:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-adoption-amjevita/ 2023-08-07T04:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/modernizing-cell-culture-processes-for-the-next-wave-of-genomic-medicine/ 2024-07-01T16:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hiv-vaccines-suffer-setbacks-but-new-approaches-could-turn-the-tide/ 2023-06-20T13:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-increase-worldwide-sales/ 2023-02-03T14:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-amgen-astrazenecas-tezspire-asthma/ 2023-02-03T11:46:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/mitigating-the-risks-of-cross-contamination-during-oral-solid-dose-osd-manufacturing/ 2023-02-03T09:22:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/karuna-goldfinch-bio-trpc4-5/ 2023-02-03T08:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-crispr-gene-therapies-cut-through-in-2023/ 2023-04-12T06:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/russias-economy-still-reels-from-the-corporate-exodus/ 2023-02-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/md-anderson-federation-bio-microbiome/ 2023-02-23T14:36:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cidara-partnership-wuxi-xdc/ 2023-02-02T11:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gsk-anaemia-ckd/ 2023-02-02T09:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/race-to-the-finish-pharma-edges-closer-to-approval-with-rsv-vaccines/ 2023-05-15T12:55:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-30-operational-growth/ 2023-02-01T14:12:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-rsv-therapies/ 2023-02-01T12:31:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ellipses-pharma-aml/ 2023-02-01T11:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uniqure-apic-bio-gene-therapy/ 2023-05-10T04:25:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-five-fdi-job-creation-projects-in-2022/ 2023-01-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daewoong-csp-ipf-therapy/ 2023-01-31T14:39:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-jp-morgan/ 2024-11-22T11:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-gas-filter-classification-standards-help-users-make-the-right-selection/ 2023-10-26T15:32:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-chmp-sandoz-hyrimoz/ 2023-02-27T05:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-therapy-designation-modernas/ 2023-01-31T09:38:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/vpas-payback-nhs/ 2023-01-30T17:48:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/decline-of-novel-drug-approvals/ 2023-01-30T15:59:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-dupixent-eosinophilic-esophagitis/ 2023-01-30T14:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/h2-2022-covid-vaccines/ 2023-01-30T12:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-jaypirca-fda-mcl/ 2023-01-30T11:41:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-oral-drugs-covid-19/ 2023-01-30T10:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-five-fdi-deals-in-2022-foreign-direct-investment/ 2023-01-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/overturn-nhs-crisis/ 2023-01-27T16:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/briumvi-multiple-sclerosis/ 2023-01-27T16:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biomarkers-ulcerative-colitis-market/ 2023-01-27T15:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-offers-refunds-for-cablivi-in-novel-model-for-rebates/ 2023-02-02T18:07:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-kite-car-t-therapy-lymphoma/ 2023-01-30T15:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-daiichi-sankyo-astrazenecas/ 2023-01-30T10:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verus-covid-19-therapy-review/ 2023-01-27T07:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/finding-cure-cell-gene-therapies-revolutionise-medicine/ 2025-06-27T14:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/poxel-pxl770-pxl065-orphan-drug/ 2023-05-04T04:59:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/money-moves-how-the-biotech-market-is-weathering-inflationary-storms/ 2023-01-31T06:57:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/africas-reliance-on-china-is-only-likely-to-get-worse/ 2023-01-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-impact-of-clinical-trial-decentralisation-on-the-pharma-supply-chain/ 2023-07-19T14:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/protacs-show-promise-for-cancer-treatment/ 2023-01-27T09:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/modernas-covid19-vaccine-sales-forecast/ 2023-05-02T12:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/utsa-researchers-gbm-tumours/ 2023-01-30T04:06:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-bioventures-avt02-saudi-arabia/ 2023-01-25T10:32:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-partner-swixx-orladeyo/ 2023-04-05T10:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-neurogene-rett-syndrome/ 2023-01-29T20:07:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-mycamine-astellas-pharma/ 2023-01-24T09:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/players-lupus-market/ 2023-05-12T04:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-licensing-hutchmed-fruquintinib/ 2023-01-23T15:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/janssen-and-eli-lilly-lack-of-paediatric-medications/ 2023-01-23T12:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disc-mabwell-antibodies-portfolio/ 2023-01-23T11:27:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lilly-boehringer-ingelheim-jardiance/ 2023-01-23T09:26:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-the-fda-keep-the-momentum-going-for-rare-disease-drug-approvals/ 2023-01-23T15:53:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-takes-aim-at-global-expansion-plans-with-manufacturing-ramp-up/ 2023-01-20T18:32:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/robo2-cardiomyopathy/ 2023-01-20T10:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-marketing-authorisations-cancers/ 2023-01-20T09:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-impact-of-climate-change-on-the-pharma-supply-chain/ 2023-06-12T14:38:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-challenges-with-scalability-in-biopharma-manufacturing/ 2023-01-20T16:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-concert-pharmaceuticals/ 2023-01-20T09:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-would-a-desantis-presidency-mean-for-the-us-and-global-economy/ 2023-01-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cell-therapies-aml/ 2023-03-03T21:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aprinoia-therapeutics-ross-business-combination/ 2023-01-19T15:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-aviditys-aoc-1020-fshd/ 2023-01-19T11:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/south-korea-novavax-covid-19-vaccine/ 2023-01-19T09:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/deciding-a-business-location-a-guide-to-investing-in-leipzig/ 2023-01-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ftx-collapse-crypto-financing-start-ups-weak/ 2023-01-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/affamed-lilly-galcanezumab-china/ 2023-01-18T15:11:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-henlius-monoclonal-antibody/ 2023-01-18T11:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orphagen-acc-therapy-fda/ 2023-01-18T09:05:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bimagrumab-trial-obesity/ 2023-01-17T16:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hospital-universitario-josep-carreras-cell-therapy/ 2023-01-17T15:53:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amylyx-neopharm-licence-agreement-als/ 2023-05-10T04:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carsgen-huadong-medicine-ct053/ 2023-01-17T09:09:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ts-lombard-what-to-expect-from-the-chinese-economy-in-2023-and-beyond/ 2023-01-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-schizophrenia-treatment-rykindo/ 2023-01-19T06:06:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/inflation-pharma-industry/ 2023-01-16T15:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ono-research-deal-monash-university/ 2023-02-23T14:23:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-momentum-biopharmaceutical/ 2023-01-16T10:54:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-tezspire-asthma-treatment/ 2023-01-16T09:07:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-therapy-manufacturing-january/ 2023-01-13T21:57:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/where-to-invest-in-arizona-us-manufacturing-tech/ 2023-01-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genetic-map-cells-endometriosis/ 2023-06-30T06:14:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/barda-sabin-ebola-sudan-marburg/ 2023-01-13T15:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-roche-influenza-treatment/ 2023-01-13T11:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-enhertu-breast-cancer/ 2023-01-13T09:01:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/solid-biosciences-phlox-cardiac-disease/ 2023-01-12T14:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/optimizing-lyophilization-cycle-times-and-improving-stability-for-complex-injectables/ 2026-04-08T14:23:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-avillion-asthma/ 2023-01-12T11:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-takeda-exkivity-nsclc/ 2023-01-12T11:56:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-ai-company-instadeep/ 2023-02-23T14:24:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/yvonne-lungershausen-interview/ 2023-01-23T13:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/new-technologies-fuel-advancements-in-digital-health/ 2023-03-21T16:43:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-union-oral-orismilast-hs/ 2023-01-11T11:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-anima-mrna-biology/ 2023-01-11T08:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/proventions-tzield-can-delay-type-1-diabetes-but-will-it-reach-all-patients/ 2023-01-13T19:48:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asklepios-recode-gene-editing/ 2023-01-10T13:57:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-3t-biosciences/ 2023-01-11T08:32:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/t2d-market-growth/ 2023-05-12T05:14:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-starts-2023-with-1-8-billion-cardiovascular-acquisition/ 2023-01-11T22:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-buy-cincor-pharma/ 2023-01-10T20:36:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-forecasts-and-trends-to-watch-in-2023/ 2023-01-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-immunome-cancer-drug/ 2023-01-09T14:05:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chiesi-buy-amryt-pharma/ 2023-01-09T12:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eisai-biogen-alzheimers/ 2023-01-09T14:00:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-we-entering-the-era-of-biologics-for-copd/ 2023-01-30T14:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/these-are-the-most-and-least-male-dominated-industries-in-the-us/ 2023-01-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exforge-antitrust-settlement-caps-novartis-year-of-legal-disputes/ 2023-01-06T19:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-duality-biologics-adc-platform/ 2023-01-06T15:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-nirsevimab-rsv/ 2023-01-06T11:21:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cell-therapies-ms-patients/ 2023-01-06T10:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/topical-products-aiming-for-quality-simplicity-and-cost-efficiency-in-their-development-scale-up-and-manufacturing/ 2023-01-06T16:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synaffix-amgen-advanced-adcs/ 2023-01-06T09:55:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-three-cross-border-ma-deals-that-shaped-healthcare-in-2022/ 2024-03-21T03:00:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capsida-prevail-gene-therapies/ 2023-01-05T16:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/inflation-pharmaceutical-sector/ 2023-01-05T16:09:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alpa-merger-carmell-therapeutics/ 2023-01-05T10:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/belharra-genentech-medicines-development/ 2023-01-05T08:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-infrastructure-investing-global-roads/ 2023-01-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maxcyte-catamaran-bio-platform-licence/ 2023-01-05T06:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-transcenta-solid-tumour/ 2023-01-04T11:13:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ondansetron-hydrochloride-cr-what-is-the-likelihood-that-drug-will-be-approved/ 2023-12-27T13:34:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-evoq-ra-lupus/ 2023-01-04T09:08:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blacksmith-medicines-forge-therapeutics/ 2023-01-03T13:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alligator-orion-oncology-research/ 2023-05-23T03:31:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alteogen-license-deal-sandoz/ 2023-01-03T09:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/biosimilar-qa-is-an-interchangeability-designation-still-relevant/ 2023-01-13T20:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/crispr-gene-therapies-is-2023-a-milestone-year-in-the-making/ 2023-06-05T05:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellectis-primera-mitochondrial-disease/ 2023-05-08T11:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-everest-iga-nephropathy/ 2023-01-02T08:01:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-humira-biosimilars-set-the-stage-for-long-awaited-2023-us-launches/ 2023-04-12T06:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/business-ecosystems-in-asset-finance-greater-than-the-sum-of-their-parts/ 2023-01-02T06:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-astrazeneca-liver-lung-cancers/ 2022-12-29T10:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-gs-1811-jounce/ 2022-12-28T09:40:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/2022-in-review-tracking-the-ups-and-downs-of-pharma-deals/ 2023-05-02T10:01:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-largest-cities-in-saudi-arabia-and-their-investment-strengths/ 2022-12-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/looking-back-at-2022-the-top-healthcare-stories/ 2022-12-27T14:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hetero-who-nirmacom-covid-19/ 2022-12-27T09:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/legochem-amgen-antibody-drug/ 2022-12-26T08:45:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gilead-hiv-treatment/ 2022-12-23T13:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-proqr-genetic-medicine-agreement/ 2022-12-23T11:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kelun-adc-deal/ 2022-12-23T08:02:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uae-out-to-prove-doubters-wrong-on-sustainability/ 2022-12-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fentanyl-disruptive-drug/ 2022-12-22T15:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-eu-joint-hta-procedure-a-gate-or-barrier-for-access/ 2024-01-29T16:41:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/excellence-awards-2022-winners-announced/ 2023-01-05T11:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/2022-in-review-regulation-starts-to-catch-up-with-ai-in-pharma/ 2023-06-13T16:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-uk-mrna-facility/ 2022-12-22T14:55:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-sobi-adc-zynlonta/ 2023-06-02T04:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/stockholm-biotech-start-life-sciences-company/ 2022-12-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/ 2023-01-04T11:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-approves-bms-breyanzi/ 2022-12-21T07:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-companies-q3/ 2022-12-20T17:11:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-marketing-atara-ebv-ptld/ 2022-12-20T13:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-rsv-therapeutic-sisunatovir/ 2022-12-20T11:07:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-competitors-are-collaborating-to-shape-biopharma-best-practices-and-regulations-of-the-future/ 2024-07-01T16:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/catalyst-buy-eisais-fycompa/ 2022-12-20T08:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-climate-denial-became-the-anti-esg-movement/ 2022-12-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-a-mild-recession-could-mean-for-small-biotechs-in-2023/ 2022-12-19T18:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/nanomilling-how-the-latest-dynamic-light-scattering-dls-technology-could-revolutionise-hydrophobic-api-production/ 2023-02-10T17:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/2022-excellence-awards-and-rankings-report/ 2024-02-02T06:55:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-innate-cancer-partnership/ 2022-12-19T12:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/new-eu-ctr-and-what-it-means-for-part-i-clinical-trial-documentation/ 2023-01-05T18:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-major-depressive-disorder/ 2022-12-19T11:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/award-shortlists-2022/ 2022-12-16T12:14:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-moderna-booster-children/ 2022-12-19T07:04:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/endometriosis-market-2030/ 2023-02-27T10:02:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/manufacturing-environment-pharma/ 2024-11-22T11:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/2022-in-review-drug-development-milestones-for-tropical-diseases/ 2023-01-23T13:20:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-lilly-small-molecules-development/ 2022-12-16T14:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-juventas-leukaemia/ 2022-12-16T11:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/t-cells-sle-therapies/ 2022-12-16T10:14:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-sanofi-dupixent/ 2022-12-16T09:29:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/early-access-france/ 2022-12-16T11:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/inflation-supply-generics/ 2022-12-15T18:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gsk-sanofi-takeda-singapore-biomanufacturing/ 2024-11-22T11:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-choose-the-right-antimicrobial-agent/ 2022-12-15T15:34:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precisionlife-ono-cns-disorders/ 2022-12-15T14:18:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-washington-university-neurodegenerative-disease-therapies/ 2022-12-15T15:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/global-cardiomyopathies-market/ 2023-01-09T11:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/congenital-fibrinogen-deficiency-market/ 2023-06-14T05:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harrow-novartis-ophthalmic-products/ 2023-02-28T04:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/guide-setting-up-manufacturing-plants-in-ohio/ 2022-12-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bacteriophages-viruses/ 2022-12-14T16:57:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-synplogen-gene-therapies/ 2022-12-14T15:56:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-wave-oligonucleotide-therapeutics/ 2022-12-14T11:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-acquire-nimbus-therapy/ 2022-12-14T08:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/data-is-the-key-to-a-safer-and-more-controlled-pharmaceutical-cold-chain/ 2023-01-05T16:08:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/invest-jamaica-2022-jamaica-is-open-for-business/ 2022-12-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lebanon-remittance-dependent-country-world/ 2022-12-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-fundamentals-of-freeze-drying-why-precise-vacuum-technology-matters/ 2022-12-20T10:47:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-mirati-therapy/ 2022-12-13T14:24:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-closes-deal-arcturus/ 2022-12-13T11:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-supply-chain-innovations-behind-the-worlds-largest-vaccine-programme/ 2023-07-03T15:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-acquire-horizon-therapeutics/ 2022-12-13T12:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/low-code-no-code-platforms-and-saas-the-next-evolution-in-clinical-trial-technology/ 2022-12-13T11:37:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-december/ 2022-12-12T16:39:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-sobi-pnh-therapy/ 2022-12-12T14:05:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-arcellx-multiple-myeloma-therapy/ 2023-04-21T12:18:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/amg-133-obesity-therapies/ 2023-01-05T06:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-pfizer-vaccine/ 2022-12-12T09:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-does-the-future-hold-for-san-antonio-economy/ 2022-12-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ash22-frontline-imbruvica-threatens-transplant-use-in-a-mcl-patient-subset/ 2022-12-11T22:44:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ash22-pirtobrutinib-emerges-as-an-option-for-richters-transformation/ 2023-01-17T10:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-takeda-dengue-vaccine/ 2022-12-09T15:58:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-metaverse-macroeconomic-trends/ 2022-12-09T13:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-entrada-eev-therapeutics/ 2022-12-09T12:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2022-solvias/ 2024-02-22T09:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-brazilian-pharma-market-key-information-and-what-may-change/ 2023-06-12T14:38:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-vaccine-pfizer-children/ 2022-12-09T09:25:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/deciding-a-business-location-where-to-invest-in-ohio/ 2022-12-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/touchlight-odimma-cancer-therapy/ 2022-12-08T14:46:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-smart-manufacturing-is-optimising-processes-and-reducing-costs-in-the-pharma-supply-chain/ 2022-12-08T16:14:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-daiichi-sankyo-liceniing-agreement/ 2022-12-08T12:02:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/chemical-synthesis-containment-challenges-for-hpapi-handling/ 2022-12-08T11:36:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-novavax-vaccine-adolescents/ 2022-12-08T08:55:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-sanofi-singapore-biologics-innovation/ 2022-12-07T14:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mhra-dupixent-use/ 2023-05-30T04:27:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-plpro-inhibitors-covid/ 2022-12-07T11:35:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/alzheimers-disease-biomarkers-galvanise-rocky-drug-development-space/ 2022-12-08T21:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-hotspot-autoimmune-disease/ 2022-12-07T09:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-five-largest-cities-in-portugal-and-their-investment-strengths/ 2022-12-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/monoclonal-antibodies-alzheimers/ 2023-02-03T12:24:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-rising-importance-of-containment-in-small-molecule-drug-development/ 2022-12-07T11:28:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evaxion-expres%c2%b2ion-cmv-vaccine/ 2022-12-06T14:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mei-kyowa-kirin-zandelisib/ 2022-12-06T11:49:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/syneos-healths-it-hiring-activity-declines-4-2-in-november-2022/ 2022-12-06T06:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/parexel-internationals-it-hiring-activity-declines-3-0-in-november-2022/ 2022-12-06T06:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/merckincs-it-hiring-activity-declines-8-6-in-november-2022/ 2022-12-06T06:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/eurofins-scientifics-it-hiring-activity-declines-10-6-in-november-2022/ 2022-12-06T06:17:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/astrazenecas-it-hiring-activity-declines-3-1-in-november-2022/ 2022-12-06T06:17:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/us-pharma-industry-it-recruitment-activity-drops-15-6-in-november-2022/ 2022-12-06T06:17:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/switzerlands-pharma-industry-it-recruitment-activity-drops-25-4-in-november-2022/ 2022-12-06T06:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/uk-pharma-industry-it-recruitment-activity-drops-25-9-in-november-2022/ 2022-12-06T06:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/spains-pharma-industry-it-recruitment-activity-drops-9-1-in-november-2022/ 2022-12-06T06:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/polands-pharma-industry-it-recruitment-activity-drops-24-4-in-november-2022/ 2022-12-06T06:17:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/irelands-pharma-industry-it-recruitment-activity-drops-11-8-in-november-2022/ 2022-12-06T06:16:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/indias-pharma-industry-it-recruitment-activity-drops-4-8-in-november-2022/ 2022-12-06T06:16:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/germanys-pharma-industry-it-recruitment-activity-drops-11-9-in-november-2022/ 2022-12-06T06:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/chinas-pharma-industry-it-recruitment-activity-drops-5-1-in-november-2022/ 2022-12-06T06:16:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/canadas-pharma-industry-it-recruitment-activity-drops-1-5-in-november-2022/ 2022-12-06T06:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/south-central-americas-pharma-industry-it-hiring-activity-drops-13-8-in-november-2022/ 2022-12-06T06:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/middle-east-africas-pharma-industry-it-hiring-activity-flat-growth-in-november-2022/ 2022-12-06T06:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/europes-pharma-industry-it-hiring-activity-drops-17-2-in-november-2022/ 2022-12-06T06:16:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/asia-pacifics-pharma-industry-it-hiring-activity-drops-7-6-in-november-2022/ 2022-12-06T06:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/north-americas-pharma-industry-it-hiring-activity-drops-15-3-in-november-2022/ 2022-12-06T06:16:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/it-hiring-in-global-pharma-industry-drops-14-7-in-november-2022/ 2022-12-06T06:16:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-eua-children-vaccine/ 2022-12-06T09:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-queensland-research-facility/ 2022-12-05T15:52:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lupkynis-approved-eu-uk/ 2022-12-05T14:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-agreement-cms-ruxolitinib-cream/ 2022-12-07T14:18:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cannabinoids-receptors/ 2022-12-07T13:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/therapeuticsmd-mayne-licensing-agreements/ 2022-12-05T09:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/humira-biosimilars-set-the-stage-for-long-awaited-2023-us-launches/ 2022-12-07T11:08:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/midterm-election-pharma-industry/ 2022-12-02T16:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ptc-therapeutics-waylivra/ 2022-12-02T14:29:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdsco-bharat-biotech-covid-19/ 2022-12-02T11:34:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-an-innovative-new-bioreactor-is-using-ultra-fine-filters-to-increase-t-cell-production/ 2022-12-02T15:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-cut-drug-supply-costs-with-seamless-forecasting-and-irt-systems/ 2022-12-02T13:34:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-actemra-iv-covid-19/ 2022-12-02T11:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-fdi-partners-also-trade-partners/ 2022-12-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/liminatus-pharma-spac-merger/ 2022-12-01T13:59:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ferring-rebyota-cdi/ 2022-12-01T12:08:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/utmb-hdt-bio-vaccine-development/ 2022-12-01T12:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/esg-washing-is-damaging-nasdaq-100-companies/ 2022-11-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-november/ 2022-12-12T16:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/whats-next-for-container-closure-integrity-testing/ 2022-12-06T11:04:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pipeline-developments-ppms/ 2022-11-30T17:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-medical-bypass-new-drugs-to-strike-obesity/ 2023-04-14T06:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-biosimilars-business-viatris/ 2022-11-30T13:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-ec-hiv-treatment/ 2022-11-30T11:46:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/city-of-hope-brain-cancer-therapy/ 2023-01-27T07:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/democracy-decline-global-authoritarianism-2022/ 2022-11-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/invest-in-lodz-poland-fdi-logistics-europe/ 2022-11-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/expanding-ketamines-horizons-to-treat-rare-neurological-disorders/ 2023-03-27T13:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-neogene/ 2022-11-29T13:42:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/full-life-acquire-focus-x/ 2023-01-11T17:07:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-bayer-darolutamide-prostate-cancer/ 2022-11-29T12:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/turkey-fdi-turkey-erdogan-investment-levels/ 2022-11-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/chinas-fdi-decline-asia-vietnam-india-indonesia/ 2022-11-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/c4xd-astrazeneca-deal-respiratory-disease/ 2023-01-04T10:11:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-remote-monitoring-tech-is-enhancing-healthcare-for-ageing-populations/ 2025-06-27T14:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-research-obesity-treatments/ 2023-01-19T09:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocytogen-adc-antibodies-cancer/ 2022-11-28T12:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/middle-east-africa-female-entrepreneurs-challenges/ 2022-11-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/artificial-intelligence-hiring-pharmaceutical-industry-q3-2022/ 2023-02-07T13:49:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/cloud-hiring-pharmaceutical-industry-q3-2022/ 2023-06-09T04:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/cybersecurity-hiring-pharmaceutical-industry-q3-2022/ 2023-06-20T08:53:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/environmental-sustainability-hiring-pharmaceutical-industry/ 2023-06-09T04:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/corporate-governance-hiring-pharmaceutical-industry-q3-2022/ 2023-06-09T04:15:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/robotics-hiring-pharmaceutical-industry/ 2023-06-09T04:15:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/social-responsibility-hiring-pharmaceutical-industry-q3-2022/ 2023-01-04T08:55:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leading-clinical-trials-companies-in-the-artificial-intelligence-theme/ 2022-11-29T09:47:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-peptide-based-compositions-for-alzheimers-disease-pharmaceutical/ 2023-01-11T13:29:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-robotics-microneedles-for-transdermal-drug-delivery-pharmaceutical/ 2023-01-06T10:11:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-iot-microneedles-for-transdermal-drug-delivery-pharmaceutical-2/ 2023-03-01T09:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-dna-polymorphism-detection-pharmaceutical/ 2024-01-05T09:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cancer-chimeric-antigen-receptor-car-t-cell-therapy-pharmaceutical/ 2023-01-05T12:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/wegovy-supply-shortage/ 2023-02-21T10:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-daiichi-sankyo-breast-cancer/ 2022-11-25T17:02:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-hormone-based-therapies-for-metabolic-disorders-pharmaceutical/ 2023-04-04T09:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-tumour-antibodies-pharmaceutical/ 2023-01-05T12:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-antibody-drug-conjugates-adc-cancer-therapy-pharmaceutical/ 2023-01-06T10:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-adeno-associated-virus-vectors-pharmaceutical/ 2023-01-06T12:33:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-recombinant-antibodies-for-cytotoxic-t-cells-pharmaceutical/ 2023-01-05T12:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-malarial-compositions-pharmaceutical/ 2023-01-05T12:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-coagulation-factor-based-compositions-pharmaceutical/ 2024-09-09T06:44:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-bridged-diaryl-derivatives-based-cancer-drug-compositions-pharmaceutical/ 2023-01-05T12:34:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-alpha-cinnamide-compositions-for-cancer-pharmaceutical/ 2023-01-05T12:28:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-bacterial-compositions-pharmaceutical/ 2023-01-06T12:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-alopecia-treatment-drugs-pharmaceutical/ 2024-08-29T04:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-affinity-chromatography-for-antibodies-pharmaceutical/ 2023-01-06T12:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-adenovirus-based-medicinal-compositions-pharmaceutical/ 2023-01-06T12:38:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-investment-healthcare/ 2022-11-26T13:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xtalpi-tumour-vaccine-platform/ 2022-11-25T16:20:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innovators-anti-malarial-peptides-pharmaceutical/ 2024-08-29T05:05:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/reinventing-the-drum-how-milling-innovations-are-cutting-costs-and-reducing-footprints/ 2023-02-10T17:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rising-demand-for-pediatric-dosage-forms-requires-reformulation-expertise-and-to-scale-manufacturing-capabilities/ 2022-12-08T12:04:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-bms-gastroesophageal-cancer-therapy/ 2022-11-25T06:59:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xeris-horizon-partnership-teprotumumab/ 2022-11-25T16:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-metaverse-regulatory-trends/ 2022-11-24T13:53:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/synthesis-to-clinic-integrating-isotopic-labeling-and-human-adme-to-reduce-time-to-clinic/ 2022-11-24T13:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biovac-oral-cholera-vaccine/ 2022-11-25T16:21:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-abbvie-skyrizi-crohns-disease/ 2022-11-24T07:42:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-regeneron-immunotherapy-cervical-cancer/ 2023-01-11T18:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-csl-haemophilia-b-therapy/ 2022-11-23T10:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/race-is-on-to-claim-share-of-biomanufacturing-market/ 2022-11-23T13:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-approval-shionogi-covid-19-drug/ 2022-11-23T07:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/best-places-to-invest-in-florida-miami-tampa-orlando/ 2022-11-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ukraines-largest-cities-their-investment-strengths-kyiv/ 2022-11-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/opinion-economic-isolation-china-risk-taiwan-invasion/ 2022-11-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chinese-manufacturers-pharma/ 2022-11-26T13:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvie-priority-review/ 2022-11-22T16:59:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-what-rishi-sunak-can-do-for-the-uk-pharma-industry/ 2023-04-12T06:44:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/umoja-iaso-therapies-haematological-malignancies/ 2022-11-22T10:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/lab-to-jab-in-100-days-manufacturing-flexibility-for-future-rapid-responses/ 2024-07-01T16:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-to-acquire-imago/ 2022-11-22T07:47:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nashville-diverse-economy-is-music-to-investors-ears/ 2022-11-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/italy-fdi-struggle-problem-eu-investment/ 2022-11-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hamilton-good-place-business-biotech-life-sciences-company/ 2024-03-21T03:00:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nona-and-dragonfly-enter-hcab-based-drug-discovery-partnership/ 2022-11-21T17:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oncology-cell-therapies/ 2022-11-26T13:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rvac-astar-mrna-manufacturing/ 2022-11-21T11:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/japanese-pharmaceutical-market-lenient-price-controls/ 2022-12-07T14:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-grants-novavax-vaccine/ 2022-12-08T07:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-major-covid-19-players-amidst-dampened-efficacy-against-omicron/ 2022-11-21T02:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/businesses-global-recession-prepared-act-now/ 2022-11-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/an-investors-guide-to-western-europe-gdp-fdi/ 2022-11-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-provention-bio-tzield-diabetes/ 2022-11-18T15:22:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-beigene-chronic-lymphocytic-leukaemia/ 2023-01-17T10:17:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-cytomx-bispecific-cancer-therapies/ 2022-11-18T09:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-recession-looming-what-does-this-mean/ 2022-11-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nice-update-endometriosis-guidelines/ 2022-11-29T14:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-ascletis-solid-tumours/ 2022-11-17T15:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-takeda-mobocertinib-lung-cancer/ 2022-11-17T12:25:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-api-cmos-can-improve-containment-capabilities-without-facility-acquisition/ 2022-11-17T09:22:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/horizon-johns-hopkins-autoimmunity/ 2022-11-17T12:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/best-areas-in-hamilton-to-invest-canada-business/ 2022-11-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-low-unemployment-rates-are-a-bad-thing/ 2022-11-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-would-be-most-affected-by-a-global-recession/ 2022-11-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nextcure-legochem-biosciences-develop-adc/ 2022-11-16T15:22:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-do-businesses-need-from-cop27/ 2022-11-18T13:41:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevatebio-affini-t-therapies/ 2022-11-16T11:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jnana-roche-discover-drugs/ 2022-11-16T11:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/possible-cause-for-paxlovid-rebound-uncovered/ 2022-11-15T17:09:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/high-foreign-born-population-affect-inward-investment-fdi/ 2022-11-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/south-carolina-good-place-start-biotech-life-sciences-company/ 2024-03-21T03:00:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indivior-to-acquire-opiant/ 2022-11-15T16:29:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exscientia-cancer-therapy-development/ 2022-11-15T11:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/prefilled-syringes-and-vaccines-optimising-parenteral-packaging-for-the-next-pandemic/ 2022-11-15T09:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-immunogen-ovarian-cancer-adc/ 2023-02-03T10:45:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/an-investors-guide-to-canada-2022/ 2022-11-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-cup-foreign-investment-fdi-qatar-2022/ 2022-11-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-gmp-manufacturing-facility/ 2022-11-14T15:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/early-cell-therapy-successes-start-to-turn-the-tide-in-lupus/ 2023-04-21T12:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/war-in-ukraine-what-it-means-for-clinical-trial-operations/ 2022-11-17T13:00:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-oncopeptides-multiple-myeloma-drug/ 2022-11-14T11:21:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-pharma-benefit-dollar/ 2022-12-07T14:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-lung-cancer-therapy/ 2022-11-14T08:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/best-cities-to-invest-in-south-carolina-investment-fdi/ 2022-11-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inflation-reduction-act-bad-news-us-manufacturing/ 2022-11-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/legal-access-for-sanctioned-entities-unclear-effects-investors/ 2022-11-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmas-growth-in-africa-needs-domestic-focus-and-investment/ 2022-11-11T18:52:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-q3-2022-revenue/ 2022-11-11T14:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approval-sanofi-gsk-booster/ 2022-11-11T11:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-sobi-covid/ 2022-11-11T09:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-manufacturers-clarity-post-brexit-industrial-policy/ 2022-11-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/royalty-pharma-interest-olpasiran/ 2022-11-10T14:43:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nrg-raises-series-a-funds/ 2022-11-10T11:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-pfizer-biontech-booster/ 2022-11-10T08:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diversification-pays-off-for-denver-fdi-investment/ 2022-11-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-new-technologies-strengthening-pharmaceutical-supply-chains/ 2022-11-09T16:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-regeneron-libtayo-chemotherapy/ 2022-11-09T14:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prophase-dana-farber-cancer-institute/ 2022-11-09T11:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/artificial-intelligence-hiring-levels-in-the-pharma-industry-dropped-in-october-2022/ 2022-11-05T20:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/can-gene-therapies-for-haemophilia-defend-their-high-price-tags/ 2023-03-16T12:28:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-t2d-lilly/ 2022-11-09T09:38:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unravel-spanios-rare-cancer/ 2022-11-09T11:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/internet-of-things-hiring-levels-in-the-pharmaceutical-industry-dropped-in-october-2022/ 2022-12-29T06:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/where-is-the-best-place-to-set-up-a-manufacturing-business-in-the-us/ 2022-11-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/net-zero-drive-up-global-demand-timber-forests/ 2022-11-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/special-focus/ukraine-crisis/ukraine-future-hub-medical-tourism/ 2024-03-21T07:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cyagen-neurophth-gene-therapy/ 2022-11-08T14:57:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viatris-oyster-point-famy/ 2022-11-08T12:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fulgent-genetics-fulgent-pharma/ 2023-01-12T17:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-pharmaceutical-industry-found-it-easier-to-fill-artificial-intelligence-vacancies-in-q3-2022/ 2022-11-05T19:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/parexel-internationals-it-hiring-activity-rises-27-9-in-october-2022/ 2022-11-08T11:19:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/merckincs-it-hiring-activity-declines-5-2-in-october-2022/ 2022-11-08T11:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/f-hoffmann-la-roches-it-hiring-activity-rises-19-8-in-october-2022/ 2022-11-08T11:37:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/eurofins-scientifics-it-hiring-activity-rises-11-4-in-october-2022/ 2022-11-08T11:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/astrazenecas-it-hiring-activity-declines-1-4-in-october-2022/ 2022-11-08T11:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/us-pharma-industry-it-recruitment-activity-drops-10-in-october-2022/ 2022-11-08T11:37:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/uk-pharma-industry-it-recruitment-activity-rises-38-2-in-october-2022/ 2022-11-08T11:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/spains-pharma-industry-it-recruitment-activity-rises-6-7-in-october-2022/ 2022-11-08T11:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/switzerlands-pharma-industry-it-recruitment-activity-drops-16-9-in-october-2022/ 2022-11-08T11:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/polands-pharma-industry-it-recruitment-activity-rises-12-2-in-october-2022/ 2022-11-08T11:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/indias-pharma-industry-it-recruitment-activity-drops-9-7-in-october-2022/ 2022-11-08T11:37:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/germanys-pharma-industry-it-recruitment-activity-drops-8-3-in-october-2022/ 2022-11-08T11:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/chinas-pharma-industry-it-recruitment-activity-drops-4-0-in-october-2022/ 2022-11-08T11:37:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/canadas-pharma-industry-it-recruitment-activity-rises-0-8-in-october-2022/ 2022-11-08T11:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/australias-pharma-industry-it-recruitment-activity-rises-4-2-in-october-2022/ 2022-11-08T11:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/south-central-americas-pharma-industry-it-hiring-activity-rises-2-0-in-october-2022/ 2022-11-08T11:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/middle-east-africas-pharma-industry-it-hiring-activity-drops-3-7-in-october-2022/ 2022-11-08T11:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/europes-pharma-industry-it-hiring-activity-rises-6-4-in-october-2022/ 2022-11-08T11:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/asia-pacifics-pharma-industry-it-hiring-activity-drops-6-9-in-october-2022/ 2022-11-08T11:38:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/north-americas-pharma-industry-it-hiring-activity-drops-9-7-in-october-2022/ 2022-11-08T11:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/it-hiring-in-global-pharma-industry-drops-6-9-in-october-2022/ 2022-11-08T11:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/an-investors-guide-to-east-asia-china-japan-korea/ 2022-11-07T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/texas-good-place-start-biotech-life-sciences-company/ 2024-03-21T03:00:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cop27-cgi-chief-sustainability-officer-mattie-yeta-on-the-first-ever-metaverse-cop/ 2022-11-10T20:40:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/meeting-global-demand-for-patient-independence-shl-medical-expands-production-in-charleston-us/ 2022-11-07T16:31:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nkgen-parkinsons-foundation-cell-therapy/ 2022-11-07T14:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cop27-how-countries-compare-on-carbon-emissions-and-pledges/ 2022-11-28T14:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-sanofi-beyfortus/ 2022-11-07T11:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-moderna-omicron-booster/ 2022-11-07T11:53:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gender-equality-in-investment-promotion-data-driven/ 2022-11-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-us-cities-for-life-sciences-investment/ 2024-03-21T03:00:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-q3-2022-total-revenues/ 2022-11-04T14:07:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/safeguarding-against-global-pharma-supply-chain-disruptions/ 2026-04-08T14:17:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reaction-biology-vyant-bio/ 2022-11-04T11:18:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/healthtech-detecting-early-risks-of-diseases-and-optimising-treatments/ 2025-06-27T14:53:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-prequalification-sinovac-vaccine/ 2022-11-04T09:33:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-can-rishi-sunak-do-for-the-uks-pharma-industry/ 2022-11-21T18:33:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-lula-means-for-business-and-foreign-investment-in-brazil/ 2022-11-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emalex-tourette-syndrome-drug/ 2023-02-16T05:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nrc-research-grant-all/ 2022-11-03T11:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ispor-europe-vienna/ 2022-11-03T10:29:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gilead-vemlidy-hbv/ 2022-11-03T09:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/recurrent-drug-shortages-signal-onerous-outlook-for-cardiovascular-care/ 2022-11-11T20:27:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/san-jose-economic-recovery-investment-tech/ 2022-11-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-revenue-q3-2022/ 2022-11-02T16:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-biopharma-industry/ 2022-11-02T12:41:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/medical-affairs-in-a-digital-first-world/ 2024-01-29T16:39:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-authorisation-astrazeneca-vaccine/ 2022-11-02T11:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascletis-ind-covid-therapy/ 2022-11-02T08:56:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/finland-tops-list-of-countries-to-relocate/ 2022-11-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-safety/ 2023-02-20T10:17:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-social/ 2023-02-20T10:18:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-status-dyne/ 2023-07-04T05:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-ma/ 2023-02-20T10:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-research-and-development/ 2023-02-20T10:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-pipeline-amyloid/ 2022-11-01T12:37:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/healthcare-in-2030-smart-toilets-robots-and-digitalisation/ 2023-01-19T06:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-product-launches/ 2023-02-20T10:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intrinsic-medicine-merger-deal/ 2023-05-31T05:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-the-european-mass-shift-to-data-driven-health-solutions/ 2023-07-07T04:19:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-orphan-status-selinexor/ 2023-05-26T04:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi-data/an-investors-guide-to-central-and-eastern-europe/ 2022-10-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/osteoarthritis-market-increase-2031/ 2023-01-09T11:13:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-abbvie-lymphoma-therapy/ 2022-10-31T14:22:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gsk-rsv-vaccine/ 2022-10-31T13:01:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-outlook-wet-amd-treatment/ 2022-10-31T11:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-actemra-covid-19-treatment/ 2022-10-31T08:01:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/bosch-develops-sensor-system-to-improve-construction-site-safety/ 2022-10-31T07:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/bayer-advances-regenerative-farming/ 2022-10-31T09:31:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/minerva-intelligence-unveils-first-canadian-climate-risk-data-api/ 2022-10-31T07:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/mit-and-toyota-improve-robotic-grasping-techniques/ 2022-11-23T09:34:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/outsourcing-it-abroad-covid-pandemic-comeback/ 2022-10-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/undefined-trials-evtol-ion-propulsion-drone/ 2022-10-31T07:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/quality-by-design-biosimilars/ 2025-06-10T14:05:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxcytes-trains-sight-on-lucrative-market-with-pneumococcal-vaccine/ 2023-05-02T12:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cloud-robotics-labs-drug-discovery-development/ 2022-10-28T15:04:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-sales-q3-2022/ 2022-10-28T14:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ptc-blackstone-financing-partnership/ 2022-10-28T11:12:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2seventy-jw-therapeutics-immunotherapies/ 2022-10-28T11:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/lay-of-the-land-understanding-lay-summary-requirements-and-the-challenges-they-bring/ 2022-10-28T08:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/foreign-investments-biotech/ 2022-11-05T18:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-medtech-platform-is-aiming-to-tackle-drug-resistant-pathogens/ 2022-10-27T14:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-seres-rcdi-therapeutic/ 2022-10-27T14:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/candel-solid-tumour-therapies/ 2022-10-27T11:20:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-health-canada-approval/ 2022-11-29T15:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-does-inflation-impact-wage-levels/ 2022-10-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmas-esg-goals-need-to-underscore-push-for-health-equity/ 2022-10-31T12:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-revenues-q3-2022/ 2022-10-28T12:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/tech-innovations-that-curb-complexity-setting-clinical-trials-up-for-success/ 2022-10-26T12:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/flexible-grinding-processes-for-sterile-nanopharmaceutical-manufacturing/ 2022-10-26T11:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-bioscience-cepi-vaccine-deal/ 2022-10-26T11:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-future-of-the-gene-therapy-market-driving-innovations-in-biotherapeutics/ 2022-10-26T11:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-janssen-tecvayli-multiple-myeloma/ 2023-08-29T04:11:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-pays-if-credit-suisse-collapses/ 2022-10-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-taysha-gene-therapy/ 2022-11-26T06:37:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/healthcare-data-management-resolving-consent-compliance-and-privacy-issues/ 2023-12-14T12:10:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-liver-cancer-therapy/ 2022-10-25T11:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/fixed-dose-combination-considerations-for-design-formulation-manufacturing-and-analysis/ 2022-10-25T12:24:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomed-sanofi-drug-development/ 2022-10-25T11:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-economic-consequence-of-a-united-ireland/ 2022-10-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-medicine-in-outer-space/ 2023-04-12T13:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/leopard-imaging-unveils-product-to-accelerate-automation/ 2022-10-31T06:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/autogrid-develops-utility-scale-virtual-power-plants/ 2022-10-31T06:06:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/cloudeats-deploys-cloud-kitchen/ 2022-10-31T06:05:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japanese-mhlw-gsk-vaccine/ 2022-10-24T08:07:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/iso-10993-7-medical-device-ethylene-oxide-sterilization-residuals-amended-to-give-specific-allowable-limits-for-neonates-and-infants/ 2022-10-24T13:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/crunch-time-for-brazil-lula-versus-bolsonaro-election/ 2022-10-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hookipa-roche-cancer-immunotherapy/ 2022-10-21T11:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-wet-amd/ 2022-11-05T19:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-acquisition-djs-antibodies/ 2022-12-03T09:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/opentext-delivers-advanced-web-application-protection/ 2022-10-28T06:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/secureworks-unveils-extended-detection-and-response-platform/ 2022-10-28T06:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/arkhia-taps-google-cloud-to-accelerate-expansion-of-distributed-ledger-applications/ 2022-10-28T06:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/loopin-streamlines-meetings-to-improve-team-productivity/ 2022-10-28T06:29:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unctad-figures-show-a-31-drop-in-fdi-flows-in-q2-2022/ 2022-10-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ogden-discount-rate-liz-truss-spooked-markets/ 2022-10-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advaxis-merger-deal-ayala/ 2022-10-20T15:40:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2022-walgreens/ 2024-02-22T09:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/wingcopter-improves-local-supply-in-rural-areas-with-delivery-drones/ 2022-10-27T12:02:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/fibocom-unveils-5g-sub-6ghz-and-mmwave-module/ 2022-10-27T11:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pic-series-a-funds/ 2022-10-20T11:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-booster-fda-eua/ 2022-10-20T11:24:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-will-netflix-do-next/ 2022-10-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/which-countries-have-the-highest-level-of-inflation/ 2022-10-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-q3-2022-sales/ 2022-10-19T15:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syncromune-eucure-antibody-deal/ 2022-10-19T11:39:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/eu-joint-procurement/ 2022-10-21T17:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-to-acquire-akouos/ 2022-10-19T11:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/columbus-ohio-rust-belt-investment-transformation/ 2022-10-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/morals-and-mergers-clash-manda-etiquette/ 2022-10-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oculis-merger-european-biotech-acquisition/ 2022-10-18T14:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novel-csf-biomarkers-signal-new-avenues-for-parkinsons-therapeutics/ 2023-01-30T15:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-gavi-covid-vaccine-deal/ 2022-10-18T11:33:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-macrogenics-antibody-development/ 2022-10-18T12:11:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/companies-conscription-russia-workers-mobilisation/ 2022-10-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi-data/an-investors-guide-to-the-eu-fdi/ 2022-10-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/software-implementation-for-asset-financers-how-to-get-it-right/ 2022-12-21T15:39:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/twindemic-europe-us/ 2022-10-17T16:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-acquires-forma-therapeutics/ 2022-10-17T14:17:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-funds-research-therapies/ 2022-10-17T11:33:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-chmp-boehringer-spesolimab/ 2022-10-17T08:11:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-catalonia-afford-independence-fdi/ 2022-10-16T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xcell-acgt-vector/ 2022-10-14T15:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enliven-imara-merger/ 2022-10-14T11:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-moderna-cancer-vaccine/ 2023-04-21T12:14:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-collaborative-partner-for-powder-processing-rd-in-universities-and-beyond/ 2022-10-14T09:04:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/phased-rollout-or-big-bang-how-asset-finance-businesses-should-implement-new-software/ 2022-10-13T17:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/asset-finance-software-migrating-legacy-data-without-making-a-mess/ 2022-10-17T15:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-evolution-in-finance-can-revolutionise-energy-efficiency/ 2022-10-14T10:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vita-therapeutics-cell-therapies/ 2023-02-14T06:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-approves-prescription-only-melatonin-drug-for-childhood-adhd/ 2022-10-13T13:58:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-a-new-cardiovascular-filtration-system-is-reducing-stroke-risk-in-tavi-transcatheter-aortic-valve-implant-for-the-patients-safety/ 2022-10-28T15:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inceptor-bio-avectas-car-t-cell/ 2022-10-13T11:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myovant-sciences-sumitomo/ 2022-11-29T14:36:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncotelic-barda-long-covid-19/ 2022-10-13T10:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-does-singapore-punch-above-its-weight-when-it-comes-to-attracting-fdi/ 2022-10-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-insulin-phase-iii/ 2022-10-12T15:14:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nimbus-lilly-metabolic-disease/ 2022-10-12T14:44:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neumora-neuro-therapies-development/ 2022-10-12T11:14:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/toregem-wuxi-antibody-development/ 2022-10-12T10:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/mercks-it-hiring-activity-declines-4-4-in-september-2022/ 2022-10-12T10:01:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/merckincs-it-hiring-activity-rises-9-3-in-september-2022/ 2022-10-12T10:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/johnson-johnsons-it-hiring-activity-declines-9-3-in-september-2022/ 2022-10-12T10:02:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/astrazenecas-it-hiring-activity-declines-13-2-in-september-2022/ 2022-10-12T10:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/us-pharma-industry-it-recruitment-activity-drops-6-6-in-september-2022/ 2022-10-12T10:02:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/switzerlands-pharma-industry-it-recruitment-activity-rises-47-7-in-september-2022/ 2022-10-12T10:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/uk-pharma-industry-it-recruitment-activity-rises-11-4-in-september-2022/ 2022-10-12T10:03:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/polands-pharma-industry-it-recruitment-activity-rises-17-4-in-september-2022/ 2022-10-12T10:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/indias-pharma-industry-it-recruitment-activity-drops-11-1-in-september-2022/ 2022-10-12T10:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/irelands-pharma-industry-it-recruitment-activity-drops-4-6-in-september-2022/ 2022-10-12T10:03:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/germanys-pharma-industry-it-recruitment-activity-drops-5-8-in-september-2022/ 2022-10-12T10:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/canadas-pharma-industry-it-recruitment-activity-drops-8-7-in-september-2022/ 2022-10-12T10:03:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/chinas-pharma-industry-it-recruitment-activity-drops-36-8-in-september-2022/ 2022-10-12T10:03:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/australias-pharma-industry-it-recruitment-activity-drops-7-9-in-september-2022/ 2022-10-12T10:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/middle-east-africas-pharma-industry-it-hiring-activity-drops-10-5-in-september-2022/ 2022-10-12T10:04:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/south-central-americas-pharma-industry-it-hiring-activity-rises-4-4-in-september-2022/ 2022-10-12T10:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/europes-pharma-industry-it-hiring-activity-rises-7-6-in-september-2022/ 2022-10-12T10:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/asia-pacifics-pharma-industry-it-hiring-activity-drops-15-5-in-september-2022/ 2022-10-12T10:04:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/north-americas-pharma-industry-it-hiring-activity-drops-6-6-in-september-2022/ 2022-10-12T10:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/jobs-data/it-hiring-in-global-pharma-industry-drops-5-7-in-september-2022/ 2022-10-12T10:04:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/brazil-elections-lula-presidency-could-signal-pharma-friendly-policies/ 2022-10-12T14:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/brexit-impact-import-consumer-costs-uk/ 2022-10-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stalicla-evgen-pharmas-sfx-01/ 2022-12-20T10:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-october/ 2022-11-30T19:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanoscope-optogenetic-therapy-fda/ 2023-02-16T05:15:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ochre-bio-rna-therapies-liver-diseases/ 2022-10-11T08:34:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inflation-drives-pharma-manufacturing-focus-on-sustainability/ 2023-02-03T09:13:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inflation-drives-pharma-manufacturing-focus-on-sustainability-2/ 2024-03-20T03:34:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/northern-ireland-potential-post-brexit/ 2022-10-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-gsk-pertussis-vaccine/ 2023-06-14T05:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/puzzel-launches-ai-powered-ccaas-packages/ 2022-10-21T13:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/female-sexual-interest-drug-reaches-tipping-point-with-phase-iii-plans/ 2022-11-30T14:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinas-selpercatinib-lung-thyroid/ 2022-10-10T11:07:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/siemens-and-deutsche-bahn-trial-hydrogen-train/ 2022-10-31T09:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/viakoo-launches-iot-security-platform-for-physical-security-service-assurance-and-cyber-hygiene/ 2022-10-31T09:54:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/milesight-and-actility-facilitate-lorawan-deployments/ 2022-10-21T13:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canada-pfizer-biontech-covid-19-booster/ 2022-10-10T08:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/rolls-royce-develops-sustainable-fuels-based-marine-engines/ 2022-10-26T10:30:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/lucidity-introduces-autonomous-storage-orchestration-solution/ 2022-10-11T09:01:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/finout-rolls-out-finops-dashboards-to-transform-cloud-costs-into-business-value/ 2022-10-11T08:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-health-concern-increases-in-september-poll/ 2022-10-10T07:32:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/sierra-develops-advanced-cellular-router-for-industrial-iot/ 2022-10-26T08:28:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/henderson-tests-ai-for-building-systems-design/ 2022-10-25T05:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/india-uae-relations-strong-fdi-investment/ 2022-10-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/falkland-islands-important-argentina-the-uk/ 2022-10-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/business-optimism-declines-in-september-2022-poll/ 2022-10-07T14:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/provention-sanofi-launch-teplizumab/ 2022-10-07T14:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europe-cannabis-market-investment-us-canada/ 2024-03-20T03:34:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lilly-tirzepatide-obesity/ 2022-10-07T11:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-expands-operations-at-existing-site-in-france/ 2024-03-20T03:34:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/surrozen-boehringer-retinal-diseases/ 2022-10-07T08:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-much-money-does-the-monarchy-bring-to-the-uk/ 2022-10-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intravacc-contract-gonorrhoea-vaccine/ 2023-01-10T05:49:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-integrate-ihc-biomarkers-for-more-effective-clinical-development-in-immuno-oncology/ 2022-10-12T09:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-global-blood-therapeutics/ 2022-10-06T11:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharmaceutical-processing-why-the-industry-is-turning-to-turnkey/ 2022-12-06T15:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biolink-funds-covid-pneumonia/ 2022-10-06T09:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi-data/how-do-the-worlds-top-fdi-locations-trade-and-invest-globally/ 2022-10-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/car-t-therapy-cll/ 2022-10-20T09:59:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/worldwide-healthtech-growth-how-the-uk-and-scotland-are-positioned/ 2025-06-27T14:43:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/irp-vaccines-uncertainties/ 2022-10-11T14:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogens-900-million-settlement-signals-scrutiny-on-speaker-fees/ 2022-10-10T16:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirecule-sanofi-muscular-dystrophy-therapy/ 2022-10-05T07:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/could-a-chinese-invasion-of-taiwan-derail-the-net-zero-transition/ 2022-10-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-is-sponsoring-the-qatar-world-cup/ 2022-10-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/joining-the-dots-how-gene-regulatory-network-tools-are-unearthing-drugs/ 2022-10-04T15:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/european-commission-mounjaro/ 2022-10-04T13:52:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-biohaven-pharmaceutical/ 2022-10-04T10:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-mpp-covid-19-antiviral-licensing/ 2022-10-04T07:57:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-us-afghanistan-humanitarian-crisis-taliban/ 2022-10-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/special-focus/ukraine-crisis/opinion-macron-france-support-for-ukraine-embarrassing/ 2022-10-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myovant-sumitovant-offer/ 2022-10-03T15:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sharing-economy-technology-trends/ 2022-10-03T12:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-zanubrutinib-waldenstroms-macroglobulinaemia/ 2022-12-20T10:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/ericsson-launches-sustainable-triple-band-tri-sector-5g-radio/ 2022-10-11T08:13:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/basf-leverages-renewable-energy-to-heat-steam-cracker-furnaces/ 2022-10-06T08:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/vmware-advances-multi-cloud-management/ 2022-10-06T08:05:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indonesia-eua-covid-vaccine/ 2022-10-03T08:12:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-hiv-pipeline-shifts-as-prep-program-discontinues/ 2022-09-30T20:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-amylyx-relyvrio/ 2022-09-30T14:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ventus-novo-nordisk-deal/ 2022-09-30T11:41:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inflarx-fda-eua-covid/ 2022-09-30T11:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russias-nation-brand-value-plummets-144bn-ukraine-invasion/ 2022-09-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-innovation/ 2023-02-20T10:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/bluebird-bio-approvals/ 2022-10-05T08:35:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-investments/ 2023-02-20T10:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pheon-adcs-solid-tumour/ 2022-09-29T14:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orphan-drug-verismo/ 2022-09-29T11:07:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-moderna-cma-vaccine/ 2022-09-29T08:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/palestine-action-protest-israel-elbit-systems/ 2022-09-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scribe-sanofi-cell-therapies-cancer/ 2022-09-28T14:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/torrent-pharma-curatio/ 2022-09-28T11:32:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-approvals-merck-keytruda/ 2022-09-28T11:32:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-melonis-election-victory-usher-in-an-anti-fdi-era-for-italy/ 2022-09-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/western-companies-russia-help-kremlin-war-mobilisation/ 2022-09-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-smallpox-antiviral/ 2022-09-27T14:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seagen-lava-licence-agreement/ 2022-09-27T11:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-omicron-booster-children/ 2022-09-27T11:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/british-pound-failing-truss-kwarteng-javed-johnson-sunak-may-hammond-cameron-osborne/ 2022-09-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-glenmark-allergic-rhinitis/ 2022-11-26T08:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-ukrainian-clinical-trial-industry-is-overcoming-disruption/ 2022-09-26T14:22:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/mecobit-advance-solar-electric-cryptocurrency-mining-rigs/ 2022-11-02T11:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/nordic-launches-ultra-low-power-dual-band-wi-fi-6-companion-chip/ 2022-09-28T15:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-alexion-ultomiris-myasthenia-gravis/ 2022-11-24T12:09:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sandoz-spin-off/ 2022-09-26T10:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/awards/rankings-financing/ 2023-02-20T10:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approval-breast-cancer-drug/ 2022-09-26T08:14:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/baidu-rolls-out-superconducting-quantum-computer/ 2022-09-30T06:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/datamotion-rolls-out-no-code-experience-for-secure-data-exchange/ 2022-09-30T12:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/duke-energy-builds-advanced-simple-cycle-gas-power-plant/ 2022-09-29T06:43:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/reveleer-offers-ai-powered-coding-capabilities-for-healthcare/ 2022-09-28T13:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/digiseq-taps-adornpay-to-launch-wearable-payment-solutions/ 2022-09-28T06:09:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/af-group-deploys-clara-analytics-for-claims-management/ 2022-09-28T05:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/east-china-sea-japan-china-senkaku-islands/ 2022-09-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mechanisms-dry-eye-syndrome/ 2022-09-23T16:12:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/three-ways-smart-site-selection-is-helping-life-sciences-companies-turn-innovation-into-commercialisation/ 2022-10-12T16:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-sitagliptin-patent-lawsuit/ 2022-09-23T14:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fennecs-hearing-loss-drug-for-cancer-patients-wins-breakthrough-fda-nod/ 2022-09-27T20:08:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rivus-development-obesity-treatment/ 2022-09-23T11:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-pharmaceutical-industry-found-it-easier-to-fill-digital-media-vacancies-in-q2-2022/ 2022-09-21T18:49:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-paxlovid-global-fund/ 2022-09-23T08:15:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/africa-new-cities-talent-continent-urbanisation/ 2022-09-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sdg-progress-measure-data-setbacks-un/ 2022-09-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-healthcare-thematic/ 2022-11-23T12:09:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-spero-licence-deal/ 2022-09-22T15:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/five-trends-in-contract-drug-manufacturing-organisations/ 2022-10-06T16:48:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rna-sequencing-developments-endometriosis/ 2023-06-15T04:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sesen-bio-carisma-merger-deal/ 2022-09-22T11:30:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abpro-celltrion-antibody-cancer/ 2022-09-22T09:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amarin-makes-moves-towards-global-expansion-of-vazkepa/ 2022-09-22T15:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-exploring-the-promise-of-billion-dollar-kras-drugs/ 2023-04-12T06:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/deciding-a-business-location-investment-strengths-of-montreal/ 2022-09-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/opinion-scotland-ireland-lessons-in-fdi/ 2022-09-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/future-of-work-hiring-levels-in-the-pharmaceutical-industry-rose-in-august-2022/ 2022-09-21T18:08:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cell-therapies-osteoarthritis/ 2023-04-21T12:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avrobio-fda-cystinosis-therapy/ 2023-06-01T10:42:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-cytoreason-extend-partnership/ 2022-09-21T11:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rocket-to-acquire-renovacor/ 2022-09-21T08:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/industrial-automation-hiring-levels-in-the-pharmaceutical-industry-rose-in-august-2022-2/ 2022-10-03T21:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/price-of-silence-doing-business-as-usual-russia-backlash/ 2022-09-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/weekly-data-interest-rate-hikes-global-recession/ 2022-09-20T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/healthtech-innovation-among-pharmaceutical-industry-companies-has-dropped-off-in-the-last-three-months/ 2022-09-20T09:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-roche-vabysmo-approval/ 2022-09-20T15:02:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-environmental-factors-could-influence-disease-and-drugs/ 2022-10-12T18:12:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genfit-to-acquire-versantis/ 2022-09-20T11:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europe-is-seeing-a-hiring-jump-in-pharmaceutical-industry-digital-media-roles/ 2022-09-21T19:04:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-nice-waldenstroms-macroglobulinemia-therapy/ 2022-09-20T08:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cmo-moves-regulatory-catalysts-for-drug-manufacturing-september/ 2023-05-12T11:35:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patagonia-esg-investment-climate-change/ 2022-09-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-gibraltar-matters-to-the-uk-and-spain/ 2022-09-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bms-opdualag-melanoma/ 2023-02-03T08:54:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-bluebird-bio-skysona/ 2022-09-19T10:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-chmp-astrazeneca-evusheld/ 2022-09-19T07:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-jasper-antibody/ 2022-09-16T15:36:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi-data/fdi-in-pharmaceuticals-in-2021-the-state-of-play/ 2022-11-25T16:16:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-specialised-therapeutics-cholangiocarcinoma/ 2022-12-29T07:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-berlingers-climate-focused-innovation-is-helping-to-reduce-remove-and-offset-emissions-from-the-pharmaceutical-supply/ 2022-09-16T15:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-veklury-who-recommendation/ 2022-09-16T11:54:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/deciding-business-location-investment-strengths-texas-arkansas/ 2022-09-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sectors/lifesciences/fdi-in-pharmaceuticals-in-2021-the-state-of-play-2/ 2022-09-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/birmingham-scientists-target-cns-injury/ 2022-09-15T14:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-cluster-effect-connectivity-and-collaboration-in-life-sciences-hubs/ 2022-09-15T14:13:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/api-landscape-in-2022-drivers-and-solutions-for-small-molecules/ 2022-10-26T13:48:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-nih-neurodegenerative-disease-treatment/ 2022-09-15T11:33:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-vaccine-companies/ 2022-11-14T13:42:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valeo-veru-sabizabulin-covid/ 2022-09-15T08:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi-data/fdi-in-healthcare-the-state-of-play-2021/ 2022-09-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esmo-2022-data-updates-push-immunotherapys-scope-in-cervical-cancer/ 2023-01-11T18:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anti-cd25-mabs/ 2022-09-14T16:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orphan-drug-syros-pancreatic/ 2022-09-14T15:30:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rayzebio-advance-cancer-radiopharmaceuticals/ 2022-09-14T11:38:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ulcerative-colitis-space/ 2023-08-07T04:12:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-til-therapy/ 2022-09-14T09:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/econsent-adoption-top-three-stumbling-blocks/ 2022-09-14T08:40:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/internet-of-things-hiring-levels-in-the-pharmaceutical-industry-rose-in-august-2022/ 2022-09-12T16:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-registration-vaccine-south-africa/ 2022-09-14T08:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/anchor-tenant-attracting-fdi-strength-weakness/ 2022-09-13T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/omicron-specific-boosters/ 2022-09-13T16:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-300m-investment-biotherapeutics/ 2022-09-13T14:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-microsoft-drug-discovery/ 2022-11-23T12:09:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2022-immunotherapy/ 2022-09-23T21:10:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2022-trodelvy/ 2022-09-13T10:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/north-america-is-seeing-a-hiring-jump-in-pharmaceutical-industry-cloud-roles/ 2022-09-12T16:54:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amerisourcebergen-to-acquire-pharmalex/ 2022-09-13T11:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/insights/weekly-data-the-global-crisis-has-strengthened-the-us-dollar/ 2022-09-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/data-analytics-hiring-levels-in-the-pharmaceutical-industry-fell-to-a-year-low-in-august-2022/ 2022-09-12T16:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-bms-sotyktu/ 2022-09-12T14:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-pfizer-children-vaccine/ 2022-09-12T12:05:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rare-disease-spotlight-ii-tracking-orphan-drugs-across-therapy-areas/ 2023-06-05T05:28:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/a-tough-puzzle-complexity-slows-drug-development-for-concussions/ 2022-09-13T15:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gladstone-institutes-covid-antiviral/ 2022-09-12T12:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-to-work-around-supply-chain-disruption/ 2022-09-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/deciding-a-business-location-investment-strengths-of-brabant/ 2022-09-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blueprint-scotland-independence-yugoslavia-economy/ 2022-09-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-inflation-reduction-act-the-moment-for-us-green-steel-and-fertiliser/ 2022-09-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/autobahn-abx-002-advancement-depression/ 2022-09-09T14:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-found-it-easier-to-fill-cloud-vacancies-in-q2-2022/ 2022-09-08T19:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gatehouse-bio-astrazeneca-rna-therapeutics/ 2022-09-09T11:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-anthos-abelacimab/ 2022-09-09T08:40:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europe-is-seeing-a-hiring-jump-in-pharma-industry-cybersecurity-roles/ 2022-09-08T19:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/the-uk-monarch-passing-queen-elizabeth-ii/ 2023-11-28T10:33:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orphan-drug-status-acelink/ 2023-05-22T07:17:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/top-tweets-paul-sax-efficacy-paxlovid-rx-covid-19-treatment-the-most-popular-tweet-in-august-2022/ 2023-05-24T04:42:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-good-therapeutics/ 2022-09-08T10:56:24+00:00 daily 0.2